Monopar Therapeutics Inc (MNPR)

Precedente Chiudi:

$0.7272

Aprire:

$0.7154

Volume 24 ore:

70,821

Capitalizzazione di mercato:

$13.00M

Reddito:

-

Utile/perdita netta:

$-9.48M

Rapporto P/E:

-0.9597

EPS:

-0.77

Flusso di cassa netto:

$-7.61M

1 W Prestazione:

+16.16%

1M Prestazione:

+25.42%

6M Prestazione:

+86.71%

1 anno Prestazione:

-23.84%

Intervallo 1D:

$0.7002

$0.7799

Portata 52W:

$0.2739

$1.75

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Nome

Monopar Therapeutics Inc

Settore

Healthcare (1223)

Industria

Biotechnology (699)

Telefono

847 388 0349

Indirizzo

1000 Skokie Boulevard, Suite 350, Wilmette

Dipendente

9

Cinguettio

Prossima data di guadagno

2024-05-09

Ultimi documenti SEC

MNPR's Discussions on Twitter

Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

GlobeNewswire Inc.

Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients

GlobeNewswire Inc.

Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks Investment Research

All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy

Zacks Investment Research

Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program

GlobeNewswire Inc.

Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari

Monopar Therapeutics Inc (MNPR) Reddito netto 2024

Monopar Therapeutics Inc (MNPR) Flusso di cassa 2024

Monopar Therapeutics Inc (MNPR) Utile per azione 2024